Bridgebio Pharma Inc logo

BBIO

Bridgebio Pharma Inc

$31.6

Earnings Summary

Revenue
$4.09Mn
Net Profits
$-177Mn
Net Profit Margins
-4326.55%

Highlights

Revenue:

Bridgebio Pharma Inc’s revenue jumped 1110.36% since last year same period to $4.09Mn in the Q3 2023. On a quarterly growth basis, Bridgebio Pharma Inc has generated 149.3% jump in its revenue since last 3-months.

Net Profits:

Bridgebio Pharma Inc’s net profit fell -19.26% since last year same period to $-177Mn in the Q3 2023. On a quarterly growth basis, Bridgebio Pharma Inc has generated -12.1% fall in its net profits since last 3-months.

Net Profit Margins:

Bridgebio Pharma Inc’s net profit margin jumped 90.15% since last year same period to -4326.55% in the Q3 2023. On a quarterly growth basis, Bridgebio Pharma Inc has generated 55.04% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Bridgebio Pharma Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.92
EPS Estimate Current Year
-0.92

Highlights

EPS Estimate Current Quarter:

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.92 - a -12.2% fall from last quarter’s estimates.

EPS Estimate Current Year:

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.92.

Key Ratios

Key ratios of the Bridgebio Pharma Inc post its Q3 2023 earnings

Earning Per Share (EPS)
-1.08

Highlights

Earning Per Share (EPS):

Bridgebio Pharma Inc’s earning per share (EPS) fell -16.13% since last year same period to -1.08 in the Q3 2023. This indicates that the Bridgebio Pharma Inc has generated -16.13% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-02
-0.82
-1.08
-31.71%
2023-05-04
-0.83
-0.92
-10.84%
2023-08-03
-0.83
-0.98
-18.07%